CASC
VIGL

Coppell Advisory Solutions Corp’s Vigil Neuroscience VIGL Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$502K Buy
3,298
+2,998
+999% +$33.7K 0.16% 126
2022
Q4 		$45.6K Buy
+300
New +$3.68K 0.02% 340

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Coppell Advisory Solutions Corp's VIGL Position: Q1 2023 in Review

Coppell Advisory Solutions Corp increased its Vigil Neuroscience (VIGL) stake by 999% in Q1 2023, buying an estimated $33.7K and bringing the position to 3,298 shares worth $502K. The position accounts for 0.16% of the portfolio, ranked #126.

Coppell Advisory Solutions Corp first reported a position in VIGL in Q4 2022 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold VIGL as of Q1 2023.

  • Coppell Advisory Solutions Corp held 3,298 shares of Vigil Neuroscience worth $502K as of Q1 2023.
  • Coppell Advisory Solutions Corp bought 2,998 Vigil Neuroscience shares in Q1 2023, an estimated $33.7K.
  • Vigil Neuroscience made up 0.16% of Coppell Advisory Solutions Corp's portfolio in Q1 2023, its #126 holding.
  • Coppell Advisory Solutions Corp first reported a position in Vigil Neuroscience in Q4 2022 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q1 2023.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2023, filed 10 May 2023.